Shenzhen New Land Tool Planning & Architectural Design Development (00456) has completed the issuance of a total of 27.649 million subscribed shares.
New City Construction Development (00456) announced that all the preconditions set forth in the subscription agreement (as supplemented by the supplemental agreement) have been fulfilled. In accordance with the terms and conditions of the subscription agreement (as supplemented by the supplemental agreement), the subscription matter was completed on May 22, 2026. The company successfully issued a total of 27.649 million subscription shares, representing approximately 14.82% of the issued share capital of the company immediately before the completion of the subscription matter; and approximately 12.91% of the issued share capital of the company after the issuance of the subscription shares. The net proceeds from the subscription matter are approximately HK$103.45 million. The company intends to use the net proceeds for general operating expenses, including payment of rent, salaries, and other administrative and operating expenses.
Shenzhen New Land Tool Planning & Architectural Design Development (00456) announced that all prerequisites listed in the subscription agreement (as supplemented by the supplemental agreement) have been fulfilled. In accordance with the terms and conditions of the subscription agreement (as supplemented by the supplemental agreement), the subscription has been completed on May 22, 2026. The company successfully issued a total of 27.649 million subscription shares, representing approximately 14.82% of the company's issued share capital prior to the completion of the subscription, and approximately 12.91% of the company's issued share capital after the issuance of the subscription shares. The net proceeds from the subscription amounted to approximately HK$103.45 million. The company intends to use the net proceeds for general working capital, including payment of rent, salaries, and other administrative and operating expenses.
Related Articles

Musk "cools down" market expectations: SpaceX delays 12th Starship test flight on the eve of its epic $1.75 trillion IPO

On May 22, JD HEALTH (06618) spent HK$29.4463 million to repurchase 729,300 shares.

Shenzhen Hepalink Pharmaceutical Group(09989): Wang Jianyi elected as employee representative director.
Musk "cools down" market expectations: SpaceX delays 12th Starship test flight on the eve of its epic $1.75 trillion IPO

On May 22, JD HEALTH (06618) spent HK$29.4463 million to repurchase 729,300 shares.

Shenzhen Hepalink Pharmaceutical Group(09989): Wang Jianyi elected as employee representative director.






